Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Controlling Progression of Myopia: Optical and Pharmaceutical Strategies

Controlling Progression of Myopia: Optical and Pharmaceutical Strategies Downloaded from http://journals.lww.com/apjoo by BhDMf5ePHKbH4TTImqenVA5KvPVPZ0P5BEgU+IUTEfzO/GUWifn2IfwcEVVH9SSn on 06/02/2020 REVIEW ARTICLE Controlling Progression of Myopia: Optical and Pharmaceutical Strategies Padmaja Sankaridurg, BOpt, MIP, PhD,*† Fabian Conrad, DipOptom, PhD,*† Huy Tran, MD*†‡ and Jianfeng Zhu, MD§ rising prevalence of myopia and aging of the population, it is Abstract: The burden associated with the rising prevalence of my- expected that there will be an increased risk of future events of opia and high myopia, and the associated vision impairment and myopic maculopathy, retinal detachment, cataract, retinal breaks, sight-threatening complications, has triggered the need to evaluate strat- and glaucoma. egies to control the progression of myopia. We provide an overview of Interplay between genetic and environmental factors has the literature on the use of optical (spectacles, contact lenses, and ortho- been shown to influence the onset and progression of myopia; keratology) and pharmaceutical approaches to slow progress of myopia. however, environmental influences are considered to play a sig - The evidence indicates that myopia progression can be slowed by varying nificant role. This is evidenced by work demonstrating modula - degrees using these strategies. All approaches play a role in the manage- 12 tion of eye growth by visual feedback in animal models, along http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png The Asia-Pacific Journal of Ophthalmology Wolters Kluwer Health

Controlling Progression of Myopia: Optical and Pharmaceutical Strategies

Loading next page...
 
/lp/wolters-kluwer-health/controlling-progression-of-myopia-optical-and-pharmaceutical-90B4Fs0wHA
Publisher
Wolters Kluwer Health
ISSN
2162-0989
eISSN
2475-5028
DOI
10.22608/APO.2018333
Publisher site
See Article on Publisher Site

Abstract

Downloaded from http://journals.lww.com/apjoo by BhDMf5ePHKbH4TTImqenVA5KvPVPZ0P5BEgU+IUTEfzO/GUWifn2IfwcEVVH9SSn on 06/02/2020 REVIEW ARTICLE Controlling Progression of Myopia: Optical and Pharmaceutical Strategies Padmaja Sankaridurg, BOpt, MIP, PhD,*† Fabian Conrad, DipOptom, PhD,*† Huy Tran, MD*†‡ and Jianfeng Zhu, MD§ rising prevalence of myopia and aging of the population, it is Abstract: The burden associated with the rising prevalence of my- expected that there will be an increased risk of future events of opia and high myopia, and the associated vision impairment and myopic maculopathy, retinal detachment, cataract, retinal breaks, sight-threatening complications, has triggered the need to evaluate strat- and glaucoma. egies to control the progression of myopia. We provide an overview of Interplay between genetic and environmental factors has the literature on the use of optical (spectacles, contact lenses, and ortho- been shown to influence the onset and progression of myopia; keratology) and pharmaceutical approaches to slow progress of myopia. however, environmental influences are considered to play a sig - The evidence indicates that myopia progression can be slowed by varying nificant role. This is evidenced by work demonstrating modula - degrees using these strategies. All approaches play a role in the manage- 12 tion of eye growth by visual feedback in animal models, along

Journal

The Asia-Pacific Journal of OphthalmologyWolters Kluwer Health

Published: Nov 1, 2018

There are no references for this article.